Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
BIOMOTION PHARMA ApS
APS
Active
Reklamebeskyttelse
CVR 12928203
Stockholmsgade 37, 2100
København Ø
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1989 · 37 years old
— employees
Overvåg
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
BIOMOTION PHARMA ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Revenue
-1
-1
16
0
-5
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-1
-1
6
-1
-5
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-1
-1
6
-1
-5
Net financials
0
5
0
0
-1
Profit before tax
-1
4
6
-1
-6
Tax
-0
-0
-0
-0
-0
Net profit
-1
4
6
-1
-6
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
3
6
12
11
8
Equity
1
5
11
10
3
Long-term debt
0
0
0
0
0
Short-term debt
1
1
1
1
4
Total debt
1
1
1
1
4
Financial ratios
5-year trend
EBITDA-margin
-531300.0%
This company
15.8%
Market median
-3362758% vs market
2020
2024
Soliditetsgrad
42.4%
This company
38.2%
Market median
+11% vs market
2020
2024
Egenkapitalforrentning
-195.2%
This company
18.4%
Market median
-1161% vs market
2020
2024
Nettoresultatgrad
-646000.0%
This company
8.1%
Market median
-7975409% vs market
2020
2024
Aktivomsætning
-0.68×
This company
1.12×
Market median
-161% vs market
2020
2024
Gæld/egenkapital
1.36×
This company
0.62×
Market median
-119% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2019-10-01 – 2020-09-30
View
PDF
More on BIOMOTION PHARMA ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
